Table 1.
GSL/Antigen Structure |
Major Expressing Cell or Expressing Cancers | Ref. |
---|---|---|
Gb3Cer/CD77 Galα1,4Galβ1,4Glcβ1,1Cer |
Burkitt lymphoma | [16] |
Gb4Cer/blood group P antigen GalNAcβ1,3Galα1,4Galβ1,4Glcβ1,1Cer |
Erythrocytes | [17] |
Gb5Cer/SSEA-3 Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ1,1Cer |
Stem cells/iPS cells | [18] |
Sialyl-Gb5Cer/SSEA-4 Siaα2,3Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ1,1Cer |
Stem cells/iPS cells | [18] |
Fucosyl-Gb5Cer/Globo-H Fucα1,2Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ1,1Cer |
Breast and other cancers | [19,20] |
Sialyl Lewisa/CA19-9-terminated GSL Siaα2,3Galβ1,3(Fucα1,4)GlcNAcβ1,3Galβ1,4Glcβ1,1Cer |
Gastrointestinal cancer | [21,22] |
GD3 Siaα2,8Siaα2,3Galβ1,4Glcβ1,1Cer |
Melanoma | [23] |
Gg4Cer (asialo-GM1) Galβ1,3GalNAcβ1,4Galβ1,4Glcβ1,1Cer |
Natural killer cells | [24,25] |
Major GSL antigens used to identify human cells are shown. Abbreviations: Cer, ceramide; Fuc, fucose; Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; GlcNAc, N-acetylglucosamine; Sia, sialic acid.